Background: To assess the prevalence of gustatory (taste) dysfunction in Long COVID-19 patients, along with type and time taken for its resolution. Methods: This is a retrospective observational study based on patients presenting to specialist smell clinic being run as part long COVID an ENT department regional hospital UK. Out all these this clinic, ones taste problems or without were included...

INTRODUCTION: SARS-CoV-2 develops well in the oral mucosa because, it is first contact area with virus. The highly expressed angiotensin-converting enzyme 2 (ACE2) and makes virus replicated epithelial cells produce both lesions symptoms. This review aimed to describe mucosal symptoms related SARS-CoV-2-infected patients that have been reported around world.EVIDENCE ACQUISITION: A literature se...

Objectives: This study was aimed to look into the prevalence of Sensory loss Smell and taste among dentists dental faculty affected with COVID-19 during current pandemic. Methods: cross sectional conducted in August, 2021, carrying out detailed evaluation onset, temporal development resolution smell 207 patients confirmatory PCR lab reports. Clinical epidemiological variables symptoms were stud...

Abstract Complications of the SARS-CoV-2 infection have significantly impacted affected people’s quality life and professional activity. Neurological manifestations may be present from onset but also in course disease. The most common neurological symptoms are headache, anosmia/hyposmia, ageusia/dysgeusia, myalgia. studies mention severe complications such as stroke, cerebral hemorrhage, mening...

ABSTRACT Objective: The aim of this study was to evaluate the relationship among following features: hyposalivation, systemic diseases and drug use, oral symptoms, dental condition, salivary flow pH, as well. Methods: A cross-sectional performed with 50 participants diagnosed xerostomia, randomly selected distributed in two groups: 25 hyposalivation without paired age sex. Unstimulated Salivary...

BACKGROUND Sunitinib has shown single-agent activity in patients with previously treated metastatic breast cancer (MBC). We investigated the safety of the combination of sunitinib and paclitaxel in an exploratory study of patients with locally advanced or MBC. METHODS Patients received oral sunitinib 25 mg/day (with escalation to 37.5 mg/day as tolerated) on a continuous daily dosing schedule...

The aim of this study was to evaluate the oral sequelae of radiotherapy in patients treated between 1999 and 2003 for head and neck tumors. One-hundred patients (24 women, 76 men) ranging in age from 30 to 83 years (mean 59.2 years) were examined. Time since radiotherapy ranged from 1 to 72 months (mean 28 months). The total mean radiation dose received by the patients was 5,955 cGy. The evalua...

OBJECTIVE To review the beneficial and harmful effects of laughter. DESIGN Narrative synthesis. DATA SOURCES AND REVIEW METHODS We searched Medline (1946 to June 2013) and Embase (1974 to June 2013) for reports of benefits or harms from laughter in humans, and counted the number of papers in each category. RESULTS Benefits of laughter include reduced anger, anxiety, depression, and stress...

OBJECTIVE To verify acceptance of hospital diets as to the nutritional status among patients admitted to the Oncology/Hematology Unit of a tertiary care hospital. METHODS A cross-sectional study conducted among 100 patients, aged ≥ 18 years, of both genders. Body mass index and subjective global nutritional evaluation by patients were used to detect the nutritional status. The rest-ingestion ...

S-1 is a novel oral anticancer drug, composed of tegafur (FT), gimestat (CDHP) and otastat potassium (Oxo), based on the biochemical modulation of 5-fluorouracil (5-FU). S-1 plus irinotecan (CPT-11) for advanced colorectal cancer as expected showed equally good results as these with CPT-11 plus infusional 5-FU/LV (FOLFIRI regimen). A case of unresectable lymph node metastasis from colon cancer ...